OÜ PharmaSeventeenRegistered
Key figures
3 417 065 €+7,6%
Revenue 2025
+60,7%
Average annual growth 2020–2025
Ratios
20250,5%
Profit margin
0,5%
EBITDA margin
−4,2%
Equity ratio
1,0×
Current ratio
−78,1%
Return on equity
706 €
Average gross salary
Profit exceeds EBITDA because of financial income (e.g. dividends or interest), which EBITDA does not include.
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 912 979 € | 16 | 13 959 € |
| Q1 2026 | 963 062 € | 15 | 14 669 € |
| Q4 2025 | 909 387 € | 11 | 15 374 € |
| Q3 2025 | 773 857 € | 11 | 18 156 € |
| Q2 2025 | 843 351 € | 9 | 15 178 € |
| Q1 2025 | 873 762 € | 7 | 15 891 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2020–2025
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||
| Total current assets | 276 934 | 369 045 | 533 463 | 584 751 | 529 990 | 550 617 |
| Total non-current assets | 576 000 | 585 926 | 519 959 | 0 | 0 | 0 |
| Total assets | 852 934 | 954 971 | 1 053 422 | 584 751 | 529 990 | 550 617 |
| Balance sheet — liabilities and equity | ||||||
| Current liabilities | 857 213 | 958 569 | 1 110 698 | 641 035 | 571 569 | 573 967 |
| Non-current liabilities | — | — | — | — | — | — |
| Total liabilities | 857 213 | 958 569 | 1 110 698 | 641 035 | 571 569 | 573 967 |
| Share capital | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 |
| Retained earnings of previous periods | — | −6779 | −6097 | −59 776 | −58 784 | −44 079 |
| Profit for the year | −6779 | 681 | −53 679 | 992 | 14 705 | 18 229 |
| Total equity | −4279 | −3598 | −57 276 | −56 284 | −41 579 | −23 350 |
| Income statement | ||||||
| Sales revenue | 318 457 | 1 849 777 | 2 153 958 | 2 514 196 | 3 174 794 | 3 417 065 |
| Operating profit | −6779 | 680 | −53 683 | 987 | 14 702 | 18 227 |
| EBITDA | 2984 | 61 809 | 12 284 | 1204 | 14 702 | 18 227 |
| Profit before income tax | −6779 | 681 | −53 679 | 992 | 14 705 | 18 229 |
| Profit for the reporting year | −6779 | 681 | −53 679 | 992 | 14 705 | 18 229 |
| Labour costs | 10 136 | 45 716 | 95 082 | 109 874 | 146 995 | 149 116 |
| Depreciation of non-current assets | 9763 | 61 129 | 65 967 | 217 | 0 | 0 |
| Other indicators | ||||||
| Employees | 0 | 1 | 3 | 3 | 4 | 4 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Ravimite jaemüük